Showing results (61-70 of 810) with videos related to
Sort By:
Pageof 81
Bulletin Du Cancer|January 1, 1992
[Lymph node metastasis of melanoma of unknown primary tumor]T Nguyen, M F Avril, P Charpentier, et al.The Journal of Investigative Dermatology|September 1, 1991
Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cellsO Azogui, M F Avril, A Margulis, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1995
Borderline and malignant serous tumor arising in pelvic lymph nodes: evidence of origin in benign glandular inclusionsM Prade, A Spatz, R Bentley, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 8, 1979
[Multiple primary malignant melanomas. A report of five cases (author's transl)]M Prade, C Bognel, S Weill, et al.European Journal of Gynaecological Oncology|June 8, 2000
Isolated para-aortic node involvement in stage IB/II cervical carcinomaP Morice, J C Sabourin, P Pautier, et al.Journal of Vascular and Interventional Radiology : JVIR|November 1, 1993
Experimental study of balloon-expandable metallic vena caval stents in rabbitsI Subbanna, T de Baere, E Therasse, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazoleR el Gamoussi, M D Threadgill, M Prade, et al.International Journal of Cancer|May 15, 1983
Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneouslyF Belardelli, I Gresser, C Maury, et al.Archiv Fur Experimentelle Veterinarmedizin|January 1, 1979
[Histochemical behavior of succinate dehydrogenase and lactate dehydrogenase as well as ribonucleic acid in the epithelium of lactic ducts and alveoli of cow udder]G MichelBulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|July 25, 2012
[The OPTIMISE study (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment]. Results for Luxembourg]G Michel, Pageof 81